Ketalar and Enoxaparin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Ketalar and Enoxaparin sodium together.

The phase IV clinical study analyzes what interactions people who take Ketalar and Enoxaparin sodium have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 24, 2022

3 people who take Ketalar and Enoxaparin sodium together, and have interactions are studied.


What is Ketalar?

Ketalar has active ingredients of ketamine hydrochloride. eHealthMe is studying from 1,168 Ketalar users for its effectiveness, alternative drugs and more.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 18,606 Enoxaparin sodium users for its effectiveness, alternative drugs and more.

Number of Ketalar and Enoxaparin sodium reports submitted per year:

Ketalar and Enoxaparin sodium drug interactions.

Common Ketalar and Enoxaparin Sodium drug interactions by gender *:

female:

  1. Abdominal infection
  2. Cardiac failure
  3. Asthenia
  4. Blood pressure decreased
  5. Chest pain
  6. Haemorrhage
  7. Pancytopenia
  8. Syncope
  9. Thrombocytopenia
  10. Confusional state

male:

n/a

Common Ketalar and Enoxaparin Sodium drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal infection
  2. Cardiac failure
  3. Asthenia
  4. Blood pressure decreased
  5. Chest pain
  6. Haemorrhage
  7. Pancytopenia
  8. Syncope
  9. Thrombocytopenia
  10. Confusional state

* Approximation only. Some reports may have incomplete information.

Do you take Ketalar and Enoxaparin sodium?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ketalar and Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ketalar interactions:

Browse all interactions between Ketalar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Enoxaparin sodium interactions:

Browse all interactions between Enoxaparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketamine hydrochloride and enoxaparin sodium (the active ingredients of Ketalar and Enoxaparin sodium, respectively), and Ketalar and Enoxaparin sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ketalar and Enoxaparin sodium.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: